ENT 200 (Rozlytrek 200 mg)
Generic Name: entrectinib
Pill with imprint ENT 200 is Orange, Capsule-shape and has been identified as Rozlytrek 200 mg. It is supplied by Genentech, Inc..
Rozlytrek is used in the treatment of non-small cell lung cancer; solid tumors and belongs to the drug class multikinase inhibitors. Rozlytrek 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ENT 200
Rozlytrek
- Generic Name
- entrectinib
- Imprint
- ENT 200
- Strength
- 200 mg
- Color
- Orange
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0094
Related Images for "ENT 200"
More about Rozlytrek (entrectinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: multikinase inhibitors
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
